Janux Therapeutics Inc
JANX
Market Cap$1.37B
Close$
$4.37
81.1% downside
Current Fair Value
81.1% downsideOvervalued by 81.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $1.32 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.28 |
| Beta | 2.96 |
| Outstanding Shares | 61,791,721 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -18.4 |
|---|---|
| PEG | -31.05 |
| Price to Sales | - |
| Price to Book Ratio | 1.44 |
| Enterprise Value to Revenue | 141.51 |
| Enterprise Value to EBIT | -11.63 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Janux Therapeutics Inc
16 employees